Your search returned 6864 results.

Results
	4701.	PD-L1 Expression, Tumor Mutational Burden, and Cancer Gene Mutations Are Stronger Predictors of Benefit from Immune Checkpoint Blockade than HLA Class I Genotype in Non-Small Cell Lung Cancer. [electronic resource] by Negrao, Marcelo V Lam, Vincent K Reuben, Alexandre Rubin, Maria Laura Landry, Lara Lacerda Roarty, Emily B Rinsurongkawong, Waree Lewis, Jeff Roth, Jack A Swisher, Stephen G Gibbons, Don L Wistuba, Ignacio I Papadimitrakopoulou, Vassiliki Glisson, Bonnie S Blumenschein, George R Lee, J Jack Heymach, John V Zhang, Jianjun Producer: 20200721 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 14 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4702.	Mismatch repair deficiency is a rare but putative therapeutically relevant finding in non-liver fluke associated cholangiocarcinoma. [electronic resource] by Goeppert, Benjamin Roessler, Stephanie Renner, Marcus Singer, Stephan Mehrabi, Arianeb Vogel, Monika Nadja Pathil, Anita Czink, Elena Köhler, Bruno Springfeld, Christoph Pfeiffenberger, Jan Rupp, Christian Weiss, Karl Heinz Schirmacher, Peter von Knebel Doeberitz, Magnus Kloor, Matthias Producer: 20190918 In: British journal of cancer vol. 120 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4703.	Immune-related adverse events are linked with improved progression-free survival in patients receiving anti-PD-1/PD-L1 therapy. [electronic resource] by Shafqat, Hammad Gourdin, Theodore Sion, Amy Producer: 20190211 In: Seminars in oncology vol. 45 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4704.	[Autoimmune-related bleeding occurring during combined immunotherapy for lung cancer - Case report]. [electronic resource] by Eberst, G Lakhzoum, W Tomasini, P Andreotti, N Abcaya, J Mascaux, C Barlesi, F Producer: 20190111 In: Revue des maladies respiratoires vol. 35 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4705.	PD-L1 expression on routine samples of non-small cell lung cancer: results and critical issues from a 1-year experience of a centralised laboratory. [electronic resource] by Vigliar, Elena Malapelle, Umberto Iaccarino, Antonino Acanfora, Gennaro Pisapia, Pasquale Clery, Eduardo De Luca, Caterina Bellevicine, Claudio Troncone, Giancarlo Producer: 20190528 In: Journal of clinical pathology vol. 72 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4706.	PD-1-expressing B cells suppress CD4 [electronic resource] by Wang, Xufu Wang, Guoqiang Wang, Zenghua Liu, Bin Han, Na Li, Jiao Lu, Chenghui Liu, Xinfeng Zhang, Qin Yang, Qingbo Wang, Guoming Producer: 20190506 In: Molecular immunology vol. 109 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4707.	Low-Dose Apatinib Optimizes Tumor Microenvironment and Potentiates Antitumor Effect of PD-1/PD-L1 Blockade in Lung Cancer. [electronic resource] by Zhao, Sha Ren, Shengxiang Jiang, Tao Zhu, Bo Li, Xuefei Zhao, Chao Jia, Yijun Shi, Jinpeng Zhang, Limin Liu, Xiaozhen Qiao, Meng Chen, Xiaoxia Su, Chunxia Yu, Hui Zhou, Caicun Zhang, Jun Camidge, D Ross Hirsch, Fred R Producer: 20200625 In: Cancer immunology research vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4708.	Cisplatin Augments Antitumor T-Cell Responses Leading to a Potent Therapeutic Effect in Combination With PD-L1 Blockade. [electronic resource] by Wakita, Daiko Iwai, Toshiki Harada, Suguru Suzuki, Miho Yamamoto, Kaname Sugimoto, Masamichi Producer: 20190423 In: Anticancer research vol. 39 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4709.	Programmed cell death ligand 1 expression in cytologic and surgical non-small cell lung carcinoma specimens from a single institution: Association with clinicopathologic features and molecular alterations. [electronic resource] by Mei, Ping Shilo, Konstantin Wei, Lai Shen, Rulong Tonkovich, Dena Li, Zaibo Producer: 20200518 In: Cancer cytopathology vol. 127 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4710.	Clinicopathologic Features of Thymoma With the Expression of Programmed Death Ligand 1. [electronic resource] by Hakiri, Shuhei Fukui, Takayuki Mori, Shunsuke Kawaguchi, Koji Nakamura, Shota Ozeki, Naoki Kato, Taketo Goto, Masaki Yatabe, Yasushi Yokoi, Kohei Producer: 20191112 In: The Annals of thoracic surgery vol. 107 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4711.	Heterogeneity of EGFR-mutant clones and PD-L1 highly expressing clones affects treatment efficacy of EGFR-TKI and PD-1 inhibitor. [electronic resource] by Kunimasa, K Nakamura, H Sakai, K Kimura, M Inoue, T Tamiya, M Nishino, K Kumagai, T Nakatsuka, S Endo, H Inoue, M Nishio, K Imamura, F Producer: 20191125 In: Annals of oncology : official journal of the European Society for Medical Oncology vol. 29 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4712.	First-line pembrolizumab in PD-L1 positive non-small-cell lung cancer: A cost-effectiveness analysis from the UK health care perspective. [electronic resource] by Hu, Xiaohan Hay, Joel W Producer: 20190813 In: Lung cancer (Amsterdam, Netherlands) vol. 123 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4713.	Thoracic and cutaneous sarcoid-like reaction associated with anti-PD-1 therapy: longitudinal monitoring of PD-1 and PD-L1 expression after stopping treatment. [electronic resource] by Paolini, Léa Poli, Caroline Blanchard, Simon Urban, Thierry Croué, Anne Rousselet, Marie-Christine Le Roux, Sarah Labarrière, Nathalie Jeannin, Pascale Hureaux, José Producer: 20200131 In: Journal for immunotherapy of cancer vol. 6 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4714.	Immune Marker Profiling and Programmed Death Ligand 1 Expression Across NSCLC Mutations. [electronic resource] by Toki, Maria I Mani, Nikita Smithy, James W Liu, Yuting Altan, Mehmet Wasserman, Brad Tuktamyshov, Rasikh Schalper, Kurt Syrigos, Konstantinos N Rimm, David L Producer: 20191001 In: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer vol. 13 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4715.	Personalized Tumor RNA Loaded Lipid-Nanoparticles Prime the Systemic and Intratumoral Milieu for Response to Cancer Immunotherapy. [electronic resource] by Sayour, Elias J Grippin, Adam De Leon, Gabriel Stover, Brian Rahman, Maryam Karachi, Aida Wummer, Brandon Moore, Ginger Castillo-Caro, Paul Fredenburg, Kristianna Sarkisian, Matthew R Huang, Jianping Deleyrolle, Loic P Sahay, Bikash Carrera-Justiz, Sheila Mendez-Gomez, Hector R Mitchell, Duane A Producer: 20181212 In: Nano letters vol. 18 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4716.	Advances in the prediction of long-term effectiveness of immune checkpoint blockers for non-small-cell lung cancer. [electronic resource] by Rebuzzi, Sara Elena Leonetti, Alessandro Tiseo, Marcello Facchinetti, Francesco Producer: 20200525 In: Immunotherapy vol. 11 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4717.	Nivolumab Alone and With Ipilimumab in Previously Treated Metastatic Urothelial Carcinoma: CheckMate 032 Nivolumab 1 mg/kg Plus Ipilimumab 3 mg/kg Expansion Cohort Results. [electronic resource] by Sharma, Padmanee Siefker-Radtke, Arlene de Braud, Filippo Basso, Umberto Calvo, Emiliano Bono, Petri Morse, Michael A Ascierto, Paolo A Lopez-Martin, Jose Brossart, Peter Rohrberg, Kristoffer Mellado, Begoña Fischer, Bruce S Meadows-Shropshire, Stephanie Callahan, Margaret K Rosenberg, Jonathan Producer: 20200605 In: Journal of clinical oncology : official journal of the American Society of Clinical Oncology vol. 37 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4718.	Role of Checkpoint Inhibition in Localized Bladder Cancer. [electronic resource] by Hahn, Noah M Necchi, Andrea Loriot, Yohann Powles, Thomas Plimack, Elizabeth R Sonpavde, Guru Roupret, Morgan Kamat, Ashish M Producer: 20191021 In: European urology oncology vol. 1 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4719.	Contribution of Aging, Obesity, and Microbiota on Tumor Immunotherapy Efficacy and Toxicity. [electronic resource] by Baiden-Amissah, Regina E M Tuyaerts, Sandra Producer: 20191227 In: International journal of molecular sciences vol. 20 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	4720.	Microsatellite-Stable Tumors with High Mutational Burden Benefit from Immunotherapy. [electronic resource] by Goodman, Aaron M Sokol, Ethan S Frampton, Garrett M Lippman, Scott M Kurzrock, Razelle Producer: 20200924 In: Cancer immunology research vol. 7 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search

Availability

Authors

Topics

Languages

Your search returned 6864 results.